Year of investment: 2010

CellMade develops and commercializes cell biology products and services: human-origin primary cells, co-culture models, customized cell isolation and characterization. CellMade also invests in its own R&D program using its CellInsight platform for identification of targets and biomarkers related to inflammatory pathologies. The company has facilities in Marseille (France) and at the Chemelot Campus.


Year of investment: 2008

Chemtrix BV supplies complete and customized microreactor systems for R&D and commercial manufacturing. Chemtrix’ microreactors enhance process efficiency, energy efficiency and safety of chemical synthesis in the fine chemical and pharmaceutical industries.

Basic Pharma

Year of investment: 2005

Basic Pharma is an advanced, independent pharmaceutical company primarily engaged in developing, licensing, manufacturing and commercialisation of pharmaceutical and biopharmaceutical products. Basic Pharma delivers a full service package to the Pharmaceutical, Biotech and Medical Device industry.


Year of investment: 2004

In 2009 the company was part of a transaction involving an MBI and which provided a partial exit for shareholders.
The assets were transferred to Fortimedix Holding BV.